Insights

Global Manufacturing Expansion Sirio Pharma's multiple state-of-the-art manufacturing sites across the United States, Germany, and China indicate a strong global footprint, creating opportunities to offer locally tailored contract manufacturing, logistics, and supply chain solutions.

Strategic Acquisition The company's recent acquisition of Best Formulations enhances its manufacturing capacity and expertise, opening doors to collaborate on innovative nutraceutical product development and customization services.

Diverse Delivery Formats With experience in gummies, softgels, powders, functional beverages, and probiotics, Sirio Pharma seeks advanced ingredients and formulations, making it a prime target for ingredient suppliers and formulation technology providers.

Growing Revenue Range Operating within the $100 million to billion-dollar revenue bracket, Sirio Pharma presents substantial sales potential for suppliers and service providers looking to scale within the nutraceutical manufacturing industry.

Technology and Innovation The company's focus on excellence in product development suggests a need for cutting-edge R&D support and technological innovations, especially in delivery formats, functional ingredients, and manufacturing efficiency enhancements.

Similar companies to Sirio Pharma

Sirio Pharma Tech Stack

Sirio Pharma uses 1 technology products and services including jQuery, and more. Explore Sirio Pharma's tech stack below.

jQuery
Javascript Libraries

Media & News

Sirio Pharma Co. Ltd acquires Best Formulations Inc..
Davis Polk advised Sirio Pharma Co. Ltd. on the deal.Sirio Pharma announced the acquisition of a majority stake of Best Formulations, as part of its strategy to meet…
Jan 15, 2023 | globallegalchronicle.com

Sirio Pharma's Email Address Formats

Sirio Pharma uses at least 1 format(s):

Sirio Pharma Email Formats	Example	Percentage
First@siriopharm.com	John@siriopharm.com	50%
First@siriopharm.com	John@siriopharm.com	50%

Frequently Asked Questions

Where is Sirio Pharma's headquarters located?

Sirio Pharma's main headquarters is located at 83 Taishan Rd., Shantou, Guangdong 515041, CN. The company has employees across 5 continents, including AsiaNorth AmericaEurope.

What is Sirio Pharma's phone number?

You can contact Sirio Pharma's main corporate office by phone at

+1-630-317-****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Sirio Pharma's official website and social media links?

Sirio Pharma's official website is siriopharm.com and has social profiles on LinkedIn.

How much revenue does Sirio Pharma generate?

As of October 2025, Sirio Pharma's annual revenue is estimated to be $501M.

What is Sirio Pharma's NAICS code?

Sirio Pharma's NAICS code is 31-33 - Manufacturing.

How many employees does Sirio Pharma have currently?

As of October 2025, Sirio Pharma has approximately 1K employees across 5 continents, including AsiaNorth AmericaEurope. Key team members include Chief Financial Officer: F. X.Vice President Global Sales: R. W.Head Of Planning: J. T. L.. Explore Sirio Pharma's employee directory with LeadIQ.

What industry does Sirio Pharma belong to?

Sirio Pharma operates in the Manufacturing industry.

What technology does Sirio Pharma use?

Sirio Pharma's tech stack includes jQuery.

What is Sirio Pharma's email format?

Sirio Pharma's email format typically follows the pattern of First@siriopharm.com. Find more Sirio Pharma email formats with LeadIQ.

When was Sirio Pharma founded?

Sirio Pharma was founded in 1993.

Sirio Pharma

ManufacturingChina1001-5000 Employees

Established in 1993, Sirio Pharma Co., Ltd (SIRIO) is a leading global nutraceutical contract development and manufacturing organization (CDMO) with extensive expertise in an array of delivery formats, including gummies, softgels, capsules, tablets, powders, functional beverages, probiotics, and other innovative dosage forms. Dedicated to excellence in product development and manufacturing. SIRIO operates multiple state-of-the-art manufacturing sites across the United States, Germany and China.
 
In 2023, SIRIO acquired Best Formulations, further solidifying its position as a premier global nutraceutical CDMO, and significantly enhancing its manufacturing capabilities and capacity – with a notable focus on bolstering its presence in North America.